|
Transcript RVX_191031_AGM
|
14
|
Resverlogix Corp.
|
Nov 01, 2019 08:51AM
|
|
Australia Associated Press
|
14
|
Resverlogix Corp.
|
Mar 03, 2021 01:57PM
|
|
Another variation
|
13
|
Resverlogix Corp.
|
Mar 04, 2021 12:52AM
|
|
Thinking back on an older discussion and wishing we had an update - Few items
|
12
|
Resverlogix Corp.
|
Jul 24, 2020 07:05AM
|
|
RVX - LD Micro Main Event Presentation 2021 10 14 - Rough Transcript
|
11
|
Resverlogix Corp.
|
Oct 19, 2021 07:40AM
|
|
Rought Transcript: RVX Presentation at GCFF Virtual Conference – Investing In Innovation – 09/10/2020
|
11
|
Resverlogix Corp.
|
Sep 18, 2020 06:06AM
|
|
Re: Rought Transcript: RVX Presentation at GCFF Virtual Conference – Investing In Innovation – 09/10/2020
|
11
|
Resverlogix Corp.
|
Sep 18, 2020 07:09AM
|
|
Re: One week later....
|
11
|
Resverlogix Corp.
|
May 21, 2021 06:54AM
|
|
Annual and Special Mtg & Corporate Update Presentation 12/22/20 - Rough Transcript
|
11
|
Zenith Epigenetics
|
Jan 05, 2021 07:19AM
|
|
RVX AGM 171212 - Rough Transcription - Not proofed or edited. Feel free to correct.
|
10
|
Resverlogix Corp.
|
Dec 14, 2017 10:04AM
|
|
Re: Interesting comment from DM
|
10
|
Resverlogix Corp.
|
Sep 30, 2019 04:09PM
|
|
Re: Apabetalone - BET protein inhibition in cardiovascular disease and Type 2 diabetes
|
10
|
Resverlogix Corp.
|
May 13, 2020 09:12AM
|
|
Rough Transcript RVX 21_05_12_PBA_at_Noon...
|
10
|
Resverlogix Corp.
|
May 13, 2021 07:56AM
|
|
RVX_2018_09_12_Trans...
|
10
|
Resverlogix Corp.
|
Sep 17, 2018 11:01PM
|
|
Re: Thoughts?
|
10
|
Resverlogix Corp.
|
Apr 08, 2021 11:46PM
|
|
Resverlogix_150929_C... (Rough, UNOFFICIAL transcript)
|
10
|
Resverlogix Corp.
|
Oct 01, 2015 09:43PM
|
|
Article
|
10
|
Resverlogix Corp.
|
May 25, 2021 05:35AM
|
|
Emergent expansion of clinical epigenetics in CVD
|
10
|
Resverlogix Corp.
|
Feb 27, 2021 11:35PM
|
|
RVX AGM 12/22/2020 - rough transcript
|
9
|
Resverlogix Corp.
|
Dec 30, 2020 03:30AM
|
|
Reiterating from ClinicalTrials.gov
|
9
|
Resverlogix Corp.
|
Sep 30, 2019 01:35PM
|
